BrazilBCI named best supply chain consultancy for biopharma | medical devices
Supply chain consultancy Buck Consultants International has won an industry award in Asia Pacific for the quality of its client work in the biopharma and medical devices sector. The firm, which has Asian hubs in China and Singapore, scooped the ‘Best Supply Chain Consulting Partner’ award during the annual Asia-Pacific Bio-Processing Excellence Awards ceremony.
More than 150 executives and managers active in the life sciences, bio-processing and bio-manufacturing sectors across Asia travelled to Singapore last week to attend the Asia-Pacific Bioprocessing Excellence Awards ceremony. Organiser IMAPAC and its judging panel had nominated dozens of organisations and individuals for the awards finale, with Buck Consultants International (BCI) coming out on top in the category for management consultancies.
Headquartered in the Netherlands, Buck Consultants International is a specialist firm for supply chain, manufacturing and location consultancy. The company, which employs 65 professionals in its offices in Europe, the US and Asia, works for clients in both the private as well as public sector.
The ‘Best Supply Chain Consulting Partner’ award is assigned to a supply chain consulting firm which according to the jury brings “exceptional expertise” in the field, and “facilitates biomanufacturing and supply chain excellence at enhanced speed, reduced cost and superior quality”. Buck Consultants International managed to receive the highest number of votes from the life sciences companies that participated in the industry contest – unknown is which other consultancies sat high in the ranks.
Sui Leng Khoo, Vice President Asia Pacific at BCI, says that the firm is humbled by the appreciation from clients. “This award is truly an honour and we thank the many healthcare companies who gave us the vote of confidence as their preferred strategic consulting partner.” She added that she believes the award further recognises BCI’s long term commitment to serving the industry, stating; “With our 33 years of experience in the biopharma and medtech industries, Buck Consultants International is in a unique position to help life sciences companies with their manufacturing, supply chain and location strategies.”
According to forecast from analysts, healthcare is a fast growing industry in the Asia Pacific region, with Singapore, South Korea, China, Taiwan, Thailand and India touted as the countries to watch for booming developments.
Patrick Haex, global leader of the supply chain consulting practice of Buck Consultants International, describes the achievement as a “great performance, not only in Asia, but also in the US and Europe . . . After all, a substantial part of our advisory work in Asia comes from European and American companies.”
BCI’s European offices are based in the Netherlands, Belgium, Germany and France, with hubs outside of Europe located in the US, the UK, China and Singapore. Haex: “We recognised ten years ago that supply chains and location choices for manufacturing plants and distribution centres would become more global. With our global footprint we can offer our services all over the world. This recognition by the health care industry will be a boost for accelerated growth.”
In another recent awards ceremony in Asia, the Big Four – Deloitte, EY, KPMG and PwC – and McKinsey & Company and Accenture were named the best consulting firms to work for in Malaysia.
